Amneal Pharmaceuticals, Inc. AMRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 38.7%+2.0pp | 36.9%+0.4pp | 36.8%+1.4pp | 37.7%+2.6pp | 36.7%+1.4pp | |
| Operating margin | 14.3%+1.6pp | 13.1%+4.1pp | 12.2%+5.2pp | 13.2%— | 12.7%— | |
| Net margin | 4%+4.5pp | 2.4%+6.6pp | 0.2%+7.1pp | 0.1%+6.8pp | -0.5%+6.3pp | |
| Returns | ||||||
| Return on invested capital | 20.1%+10.7pp | 15.7%+5.2pp | 13.4%+5.9pp | 10.1%+3.2pp | 9.4%+3.1pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×+0.1× | 0.8×0.0× | 0.8×+0.1× | 0.8×+0.1× | 0.8×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.5×+1.1× | 2.2×+0.8× | 2.1×+0.8× | 1.4×+0.1× | 1.4×-0.3× | |
| Per Share | ||||||
| Book value per share | -$0.14+66.0% | -$0.22+38.3% | -$0.34-11.7% | -$0.35-93.0% | -$0.41-95.9% | |
| Valuation | ||||||
| Market capitalization | $3.97B+51.0% | $3.96B+61.4% | $3.14B+22.1% | $2.55B+30.0% | $2.63B+40.4% | |
| Price / earnings | 32.5×— | —— | —— | —— | —— | |
| Price / sales | 1.3×+0.4× | 1.3×+0.4× | 1.1×+0.1× | 0.9×+0.1× | 0.9×+0.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amneal Pharmaceuticals, Inc.'s profit margins?
- Amneal Pharmaceuticals, Inc. (AMRX) runs a 38.7% gross margin and a 14.3% operating margin, with a 4.0% net margin.
- Where do Amneal Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Amneal Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
